The Clinical Value and Variation of Antithyroid Antibodies during Pregnancy

Abstract EN

Antithyroid antibodies, which include thyroid-stimulating hormone receptor antibodies (TRAbs), thyroid peroxidase antibodies (TPOAbs), and thyroid globulin antibodies (TgAbs), are widely known for their tight association with thyroid autoimmune diseases.

The variation in all three kinds of antibodies also showed different trends during and after pregnancy (Weetman, 2010).

This article reviewed the the physiological changes, while focusing on the variation of thyroid antibodies concentration in women during and after pregnancy, and adverse consequences related to their elevation.

Since abnormal elevations of these antithyroid antibodies may lead to adverse outcomes in both mothers and fetuses, special attention must be paid to the titer of the antibodies during pregnancy.

The molecular mechanisms of the variations in those antibodies have yet to be explained.

The frequency and timing of thyroid antibody measurement, as well as different reference levels, also remain to be elucidated.